Full Text View
Tabular View
No Study Results Posted
Related Studies
The Natural History of Geographic Atrophy Progression (GAP) Study
This study has been terminated.
Study NCT00599846   Information provided by Alcon Research
First Received: January 13, 2008   Last Updated: October 1, 2009   History of Changes

January 13, 2008
October 1, 2009
December 2007
June 2010   (final data collection date for primary outcome measure)
GA progression rate using fundus autofluorescence [ Time Frame: From baseline ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00599846 on ClinicalTrials.gov Archive Site
GA progression rate using fundus photography [ Time Frame: From baseline ] [ Designated as safety issue: No ]
Same as current
 
The Natural History of Geographic Atrophy Progression (GAP) Study
 

The objective of the 18-month trial is to evaluate the natural history of geographic atrophy by assessing the rate of progression of the geographic atrophic lesion over time.

 
 
Observational
Case-Only, Prospective
  • Age-Related Macular Degeneration
  • Geographic Atrophy
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Terminated
1000
 
June 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of geographic atrophy secondary to age-related macular degeneration with no CNV lesion.

Exclusion Criteria:

  • Age related
Both
55 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00599846
Patricia Zilliox, Alcon
C-06-30
Alcon Research
 
Study Director: Patricia Zilliox Alcon Research
Alcon Research
October 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP